MedPath

Effect of Qingshen Granules on renal outcome in chronic kidney disease stage 3-4 patients with damp-heat syndrome and safety of Qingshen granules:a real-world multicenter, prospective cohort study

Not Applicable
Conditions
chronic kidney disease stage 3-4 patients with damp-heat syndrome
Registration Number
ITMCTR2100005173
Lead Sponsor
the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged 18 to 70 years, male or female;
2. Meet the diagnostic criteria of CKD stage 3a-4, as well as the syndrome differentiation criteria of TCM damp-heat syndrome;
3. Blood pressure <140/90mmHg, serum potassium <5.5mmol/L, hemoglobin >=80g/L, infection under control, and stable condition for more than 2 weeks at the time of enrollment;
4. Sign the informed consent.

Exclusion Criteria

1. Pregnant or lactating patients;
2. Unable to cooperate, such as mental patients;
3. Combined with serious primary diseases such as active malignant tumor, decompensated liver cirrhosis or hematopoietic system;
4. Patients with infectious diseases;
5. There is acute urinary tract obstructive disease, requiring surgical treatment;
6. Severe arrhythmia, severe heart failure, NYHA class III and above (evidence of New York Heart Association class III and IV), or myocardial infarction or cerebrovascular events within 3 months before enrollment;
7. Are using corticosteroids, non-steroidal anti-inflammatory drugs or immunosuppressants;
8. Those undergoing emergency hemodialysis;
9. Those who have undergone kidney transplantation and total or partial parathyroidectomy;
10. Those who are known to be allergic to or intolerable to a certain drug in this study; patients who are participating in other clinical trials.

Study & Design

Study Type
Treatment study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood creatinine doubled;First dialysis;
Secondary Outcome Measures
NameTimeMethod
Mineral and bone metabolism indexes;Cardiovascular events;Detection of vascular calcification;
© Copyright 2025. All Rights Reserved by MedPath